p53 constrains progression to anaplastic thyroid carcinoma in a <i>Braf</i> -mutant mouse model of papillary thyroid cancer
David G. McFadden(Southwestern Medical Center), Tyler Jacks(Massachusetts Institute of Technology), Amanda Vernon(Massachusetts Institute of Technology), Peter M. Sadow(Massachusetts Eye and Ear Infirmary), Raúl Martinez-McFaline(Massachusetts Institute of Technology), Denise M. Crowley(Massachusetts Institute of Technology), Martin McMahon(University of Utah), Arjun Bhutkar(Massachusetts Institute of Technology), Philip M. Santiago(Massachusetts Institute of Technology)
Cited by 169
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
|Nature|2009|4.2k
Restoration of p53 function leads to tumour regression in vivo
|Nature|2007|1.8k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k